Viewing Study NCT04001361


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2025-12-31 @ 7:13 AM
Study NCT ID: NCT04001361
Status: UNKNOWN
Last Update Posted: 2019-06-28
First Post: 2019-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Laser Cell Therapy for Knee Cartilage Repair
Sponsor: Endocellutions
Organization:

Study Overview

Official Title: Combined Effect of IPG Medical Charlie Laser and Bone Marrow Grafting on Cartilage Defects of the Knee
Status: UNKNOWN
Status Verified Date: 2019-06
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Laser pulsed energy will be delivered over an optical fiber to create channels into damaged cartilage of the knee or knees. The channels have a diameter of approximately 100 microns or less and an approximate depth of 1 millimeter or less. Bone marrow aspirate will then be delivered into the damaged joint.
Detailed Description: The creation of micro-channels into damaged knee cartilage will facilitate the movement of fluid into and out of the tissue to allow for more efficient nutrient diffusion. The addition of bone marrow aspirate will provide additional growth factor enriched nutrition to the tissue. The goal of this combination therapy is to facilitates the body's own reparative processes leading to improved patient well being.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: